Slide 1: PI Industries Ltd. Investor Presentation Q3 FY25 Result
PI Industries Ltd. Investor Presentation Q3 FY25 Result 1
Slide 2: Agenda
AGENDA CDR India Siddharth Rangnekar • Consolidated Financial Performance siddharth@cdr-india.com Nishid Solanki • Key Updates nishid@cdr-india.com Tel: +91 22 6645 1221 /1209 • Business Model and Strategy Fax: +91 22 6645 1213 • ESG Credentials PI Industries Limited • Rewards & Recognition Rajnish
Slide 3: Stable Performance amidst Challenging Market Dynamics
Stable Performance amidst Challenging Market Dynamics… Reflecting strong business model and disciplined execution Revenue EBITDA PAT Figures in Rs. Million *Q3FY25 19,008 0.2% 5,122 8% 3,727 17% *9MFY25 61,907 4% 17,264 9% 13,297 1% Commercialised Cash flow from Trade working 6 new products in New p
Slide 4: Consolidated revenue and margins maintained in Q3
Consolidated revenue and margins maintained in Q3 Strong recovery of Domestic revenues Fig in Rs. Million Q3FY24 Q3FY25 % YOY ▪ Overall flat revenue (3-year Q3 CAGR 12%). ▪ ~2% growth in Agchem Exports (Volume up ~5%) and growth of new Revenue 18,975 19,008 0.2% products1 ~40% Y-o-Y. Gross Margin 54
Slide 5: Growth of new products remained key feature of 9MFY25
Growth of new products remained key feature of 9MFY25… ..offsetting inventory pressure of legacy products Fig in Rs. Million 9MFY24 9MFY25 % YOY ▪ Overall 4% Y-o-Y revenue growth (3-year 9MFY25 CAGR 17%) ▪ ~9% growth in Agchem Exports over a high base mainly on account Revenue 59,248 61,907 4% of vo
Slide 6: Free cash generation on a strong balance sheet
Free cash generation on a strong balance sheet … driving growth investments Fig in Rs. Million Dec-23 Mar-24 Dec-24 Highlights of 9MFY25 Shareholders Fund 84,508 87,310 98,660 Non Current Liabilities 3,082 3,224 3,406 Long term borrowings 697 617 456 ▪ Increase in Networth by Rs. 11,350 million to R
Slide 7: World-class R&D set-up delivering innovative and disruptive solutions
World-class R&D set-up delivering innovative and disruptive solutions State-of-the-art NABL ISO17025 and GLP R&D R&D Labs certified at 4 locations New ICP-OES 1st Indian company to receive approval from International 700+ Scientists 60+ projects at Organization for 200+ Doctorates different developm
Slide 8: Agchem CSM, a global leader, backed by strong technological strengths
Agchem CSM, a global leader, backed by strong technological strengths Technology pioneer 14 with technological and IP based interventions in global ✓ ISO-certifications contract manufacturing ✓ Golden Batch Tool 15 Fully automated Multipurpose ✓ 2 dedicated scale-up 2 Plants (MPPs) facilities at Uda
Slide 9: Over 6 decades of bringing innovation to Indian farmers
Over 6 decades of bringing innovation to Indian farmers and creating market leader brands … Crop Solutions HORTICULTURE RICE SOYBEAN WHEAT CHILLI COTTON CORN 9
Slide 10: Momentum for launching new innovative products continued
Momentum for launching new innovative products continued... FY23 Provide® Dinoace Sectin® Brofreya® Ultimare® Taurus® Tomatough® Herbicide for Cotton Dual action Combination Revolutionary Novel Model of Nematicide for Biological product insecticide for Fungicide Insecticide action vegetable crops fo
Slide 11: Deep engagement with farmers and channels with innovative approaches
Deep engagement with farmers and channels with innovative approaches Farmer Channel Precision Connect Connect Farming Services • 5 product launches • 50,000+ retailer connect • 10,000+ farmers served • 10 major product campaigns across multiple marketing across 600+ villages with campaigns spraying
Slide 12: Biologicals, our passion for over 2 decades
Biologicals, our passion for over 2 decades... A comprehensive smart biological portfolio being built AMINOGROW SIAPTON® RAPIGRO Lq. RAPIGRO ARMATURA® ACTIV GR. over the last 20 years BIOVITA® PIILIN® BIOVITA® JB07 GRANULES LIQUID Biologicals revenue fastest growing at CAGR of 20%+ over last 3-years
Slide 13: Technology: Harpin Protein
Harpin Protein History Unique Biostimulants technology Class of proteins, harpins, that function 0 in nature as warning compounds 1 HARPIN⍺β BINDS TO TRIGGERS GROWTH Derived from “Hypersensitive Response PLANT CELL AND DEFENCE 0 4 ACTIVE DOMAINS & Pathogenicity N” gene (HrpN) RECEPTORS RESPONSE TECH
Slide 14: PIHS: Build-up of a differentiated CRDMO platform
PIHS: Build-up of a differentiated CRDMO platform with high quality of Talent, Assets, Processes and Customer Portfolio TALENT CUSTOMER ASSETS Initiated global pharma and biotech companies visit to newly refurbished facilities at Hyderabad and Jaipur Invested capex of Rs Dr. Ramesh Subramanian 2,000
Slide 15: PIHS: FY25 financials reflect transition to new business model
PIHS: FY25 financials reflect transition to new business model and development spend Fig in Rs. Million Q3FY24 Q1FY25 Q2FY25 Q3FY25 ▪ Sequential Q-o-Q revenue recovery in Q3FY25 Revenue 1,273 253 411 637 ▪ Key CDMO order secured for new program Gross Margin 51% 42% 59% 48% Overheads 650 611 879 657
Slide 16: Transitioning from Ag Science to Life Sciences company
Transitioning from Ag Science to Life Sciences company 350 300 300+ 250 250+ Global market ($ bn) 200 Pharma 150 From pure play Agrochemicals CSM & CRDMO 100 50 Distribution opportunity of ~15-20 Bn 0 2021 2022 2023 2024 2025 2026 2027 2028 2021 Discovery Pre-clinical dev. Clinical dev. CMO 2028 of
Slide 17: Outlook remains positive amid transitory industry headwinds
Outlook remains positive amid transitory industry headwinds • Demand expected to improve in second half of CY25 CSM Export: • Continued scale-up of products commercialized over the last 3-years Technology focused approach • Capacity expansion in line with plan to drive incremental business • Momentu
Slide 18: PI the company
PI the company known for over 2 decades to be the Top wealth creator . . . An organization that is committed to excellence in whatever it does . . . “Outshines competitors in delivering business needs of the customers by unlocking value & fearlessly reinventing ourselves ” A Trusted Brand & Successf
Slide 19: Our Global Presence
Our Global Presence Germany India Amsterdam Milan Raleigh Japan Alabama China India Sao Paulo Offices in India, US, Italy, Japan, Netherlands, China, Brazil and Germany Registered Office Our Export Markets Corporate Office Global Offices R&D Manufacturing Units 30+ 8 4,000+ 8 25+ 15,000+ 100,000+ Depots
Slide 20: Lead with science, technology and human ingenuity
“Lead with science, technology and human ingenuity to create transformative solutions in life sciences” Partner Science & Digital Edge People First ESG Centric Technology Anchored Driven Integrated digital Best opportunities First to identify solutions to gain for employees to ESG the way of & deliv
Slide 21: Agchem Business model built on respect for IP and relationships
Agchem Business model built on the principles of respect for IP and established relationships Leading Agchem Distribution India’s largest CRAMS Company Company in India with Domestic Brand Market with majority revenue from Exports Market leading market share in Patented Products certain crops Levera
Slide 22: Multipronged strategy to sustain the growth momentum
Multipronged strategy to sustain the growth momentum backed by multiple growth engines & aggressive M&A Market • Expansion Build Explore and exploit • Creation Customer Intimacy untapped chemistry • Segments Product & areas Deepening our technological capabilities to open new Customer-centric servic
Slide 23: PI in the S&P Global Sustainability Yearbook 2024
PI in the S&P Global Sustainability Yearbook 2024 Ranked among the Top 3 percentile of ESG Rated companies globally… Our 2025 Goal SDG alignment Our achievement Our 2025 Goal SDG alignment Our achievement Carbon emissions intensity in terms of (from FY2021) (from FY2021) revenue from operations (₹ m
Slide 24: Our CSR efforts focused on community welfare & environment
Our CSR efforts focused on community welfare & environment CSR policy directed towards inclusive development that creates value for the society Education Health & Women & Skill Environment Hygiene Empowerment Development Sustainability Health & wellness support for rural • Program running in 80 rura
Slide 25: Rewards and Recognition
Rewards and Recognition Most Promising Company Barclays Private Client Most Preferred of the Year Hurun India Award 2024 Workplace 2024-25 by CNBC TV18 India Business for Leadership Excellence and Vision by Marksmen Daily Leader Awards (IBLA) India’s Best Trailblazer CEO India's Top Value Creator PI
Slide 26: Thank You
Inspired by Science “% ~=Thank You 26